These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
838 related articles for article (PubMed ID: 19563521)
1. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
2. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028 [TBL] [Abstract][Full Text] [Related]
3. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data. Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
6. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea. Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187 [TBL] [Abstract][Full Text] [Related]
7. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J; Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886 [TBL] [Abstract][Full Text] [Related]
8. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Gross CP; McAvay GJ; Guo Z; Tinetti ME Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973 [TBL] [Abstract][Full Text] [Related]
9. Survival and time interval from surgery to start of chemotherapy among colon cancer patients. Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115 [TBL] [Abstract][Full Text] [Related]
10. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer. Panchal JM; Lairson DR; Chan W; Du XL Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529 [TBL] [Abstract][Full Text] [Related]
11. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy. Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395 [TBL] [Abstract][Full Text] [Related]
12. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519 [TBL] [Abstract][Full Text] [Related]
14. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1. André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423 [TBL] [Abstract][Full Text] [Related]
15. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Cheung WY; Neville BA; Earle CC Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846 [TBL] [Abstract][Full Text] [Related]
16. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916 [TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118 [TBL] [Abstract][Full Text] [Related]
20. Acuity and survival in colon cancer surgery. Paulson EC; Mahmoud NN; Wirtalla C; Armstrong K Dis Colon Rectum; 2010 Apr; 53(4):385-92. PubMed ID: 20305436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]